Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Vertex Europe (UK) — Cost of sales by Year
Vertex Europe (UK) — Cost of sales ($M) ($M)
Vertex Pharmaceuticals Vertex Europe (UK) — Cost of sales: $9,070M in FY2025, up 2.8% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
“Cost of sales (9,069,995) (8,821,453)”
Source: Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
Reported in UK Companies House Statutory Accounts (02907620, OCR).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vertex Europe (UK) — Cost of sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9,070 | +2.8% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2024 | Dec 31, 2024 | 8,822 | +32.3% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2023 | Dec 31, 2023 | 6,669 | +24.4% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2022 | Dec 31, 2022 | 5,363 | +0.4% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2021 | Dec 31, 2021 | 5,339 | +6.8% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2020 | Dec 31, 2020 | 4,997 | +36.2% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2019 | Dec 31, 2019 | 3,669 | +19.7% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2018 | Dec 31, 2018 | 3,064 | – | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Vertex Europe (UK) — Cost of sales ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/uk-eur-cogs
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.